SCALANOVA HEALTH·Oct 21MedTech Hardware-as-a-Service (HaaS) FinOps: Automating Usage Metering and ASC 606 Revenue…Automate telemetry-driven billing, dynamic ASC 606 revenue allocations, and FASB ASU 842 lease accounting using dedicated client-owned…
InBeingWellbyGil Bashe·Sep 6When the Data Disappoints: the Enduring Flame of Hope in Biopharma ResearchThe Human Impact of Scientific Disappointment and Why Profit and Purpose Must Co-Exist
Gyan Solutions Health & Life Sciences·Jul 31The Forecast Wasn’t Wrong. It Was Never Independent.When a demand number and a sales target are the same figure, nobody can tell you’re wrong until the inventory is already sitting on the…
InZS AssociatesbyZS·Jul 17Why biopharma launch performance depends on stronger operating systemsFor many biopharma launch teams, readiness can look convincing from the inside. Milestones are tracked, dashboards are reviewed…
Po-Sung (Sinclair) Huang·Mar 25Why 156,000 Citations Can Be Worth Less Than 18,700 in BiopharmaA new working paper suggests that markets often reward narrative clarity more than scientific spillovers.
smartData Enterprises·Oct 9, 2025Accelerating Biopharma Research: The Rise of AI and Agentic Agents in Early-Stage DiscoveryThe world of biopharma is changing faster than ever. For decades, the early stages of drug discovery have been a slow, expensive process…
Robert Stavros·Apr 10, 2025What If Molecules Were Metadata?We argue about medicine as if we’re trading pills, syringes, and packaging. However, the U.S. exports patents, processes, and invisible…
ikenna.·Jan 19, 2025#3: NanoDDS Weekly Roundupevery week I do a roundup of papers I read during the week. most of the selected papers I read are focused on nanomedicine, drug delivery…A response icon1A response icon1
InInsiderFinance WirebySteve F·Dec 3, 2024Pharmaceutical Stocks in DepthNumerous elements are known to affect the stock prices of companies. These factors encompass earnings reports, dividend announcements…
InHealth decodedbyInvitae® (a Labcorp company)·Sep 23, 2024Rare disease research benefits from large clinical and genomic datasetsUnique, deep data help current research in drug discovery meet the challenge of finding new treatments for rare genetic diseases
